Company Profile

    Profound Medical Corp. is a medical technology company focused on a therapeutics platform that provides the precision of real-time Magnetic Resonance Imaging combined with the safety and ablation power of directional and focused ultrasound technology for the incision-free ablation of diseased tissue. Profound Medical is publicly traded on TSX (PRN) and on NASDAQ (PROF).

    [stock_market_widget type=”inline-label” template=”basic” color=”default” assets=”PRN.TO” api=”yf”]

    Head Office

    2400 Skymark Avenue, Unit 6
    Mississauga, ON Canada L4W 5K5

    Investor Relations

    Stephen Kilmer
    Investor Relations
    skilmer@profoundmedical.com
    647.872.4849 (Canada)
    646.274.3580 (U.S)

    Governance

    Arun Menawat, Chairman
    Arthur Rosenthal (2)(3)
    Brian Ellacott (4)
    Cynthia Lavoie (2) 
    Murielle Lortie (1)
    Kris Shah (4)

    (1)     Audit Committee Chairman
    (2)     Audit Committee Member
    (3)     Human Resource and Corporate Governance Committee Chairman
    (4)     Human Resource and Corporate Governance Committee Member

    Committee Charters

    Articles of Incorporation – June 13, 2008
    Articles of Amendment – June 3, 2015
    Articles of Amalgamation – June 4, 2015
    By-Laws

    Code of Business Conduct and Ethics
    Anti-Harassment, Anti-Violence  and Anti-Discrimination Policy
    Cybersecurity Policy
    Whistleblower Procedures
    Modern Slavery Report

    Majority Voting Policy
    Board Mandate

    Position Description of CEO
    Position Description of Chairman of the Board

    Presentations

    Title
    Investor Presentation

    Investor Presentation with video

    TULSA-PRO Procedure Video
    TULSA-PRO Case (Axial Image) Video

    TACT Data

    DOCUMENT
    TACT Data press release
    TACT Data presentation

    Webcasts

    Q2 2024 Financial Results Conference Call Webcast – August 8, 2024

    Q1 2024 Financial Results Conference Call Webcast – May 9, 2024

    2024 Bloom Burton & Co. Healthcare Conference – April 16, 2024

    Barclays 26th Annual Global Healthcare Conference – March 13, 2024 

    Q4 & Full Year 2023 Financial Results Conference Call Webcast – March 7, 2024

    Stifel 2023 Healthcare Conference 0- November 15, 2023

    Q3 2023 Financial Results Conference Call Webcast – November 2, 2023

    Profound Medical Analyst Day (Video)- Oct 13, 2023  

    2023 Cantor Global Healthcare Conference – September 26, 2023

    Q2 2023 Financial Results Conference Call Webcast – August 9, 2023

    2023 Jefferies Healthcare Conference – June 7, 2023

    Q1 2023 Financial Results Conference Call Webcast – May 10, 2023

    2023 Bloom Burton & Co. Healthcare Investor Conference – April 26, 2023

    TD Cowen Health Care Conference – March 8, 2023

    Q4 & Full Years 2022 Financial Results Conference Call Webcast – March 7, 2023

    Jefferies London Healthcare Conference Call Webcast – November 15,2022 

    Q3 2022 Financial Results Conference Call Webcast – November 3, 2022

    Q2 2022 Financial Results Conference Call Webcast – August 4, 2022

    Jefferies Global Healthcare Conference – June 9, 2022

    Q1 2022 Financial Results Conference Call Webcast – May 9, 2022

    Bloom Burton & Co. Healthcare Investor Conference May 2, 2022

    Raymond James 43rd Annual Institutional Investors Conference March 9, 2022

    42nd Annual Cowen Health Care Conference March 7, 2022

    Q4 & Full Year 2021 Financial Results Conference Call Webcast – March 3, 2022

    Jefferies London Healthcare Conference – November 18, 2021

    Q3 2021 Financial Results Conference Call Webcast – November 4, 2021

    Cantor Virtual Global Healthcare Conference – September 30, 2021

    Q2 2021 Financial Results Conference Call Webcast – August 4, 2021

    Virtual Raymond James Human Health Innovations Conference – June 22, 2021

    Jefferies Virtual Healthcare Conference – June 1, 2021

    Annual Shareholders Meeting Presentation – May 19, 2021

    Q1 2021 Financial Results Conference Call Webcast – May 12, 2021

    Bloom Burton & Co. Healthcare Investor Conference April 21, 2021

    Cowen 41st Annual Health Care Conference March 4, 2021

    Raymond James 42nd Annual Institutional Investors Conference – March 3, 2021

    Q4 & Full Year 2020 Financial Results Conference Call Webcast – March 2, 2021

    BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference – February 18, 2021

    Jefferies Virtual London Healthcare Conference – November 17, 2020

    Q3 2020 Financial Results Conference Call Webcast – November 05, 2020

    Cantor Virtual Global Healthcare Conference – September 17, 2020

    Canaccord Genuity 40th Annual Growth Conference – August 13, 2020

    Q2 2020 Financial Results Conference Call Webcast – August 6, 2020

    Q1 2020 Finance Results Conference Call Webcast – May 7,2020

    Discussion Hosted by Raymond James Research Department – March 26,2020

    Cowen and Company 40th Annual Health Care Conference – March 4,2020

    Q4 and Full Year 2019 Financial Results Conference Call Webcast – March 3, 2020

    BioTuesdays Pre-JPM Virtual Conference-  December 10, 2019

    Canaccord Genuity 13th Annual Medical Technologies & Diagnostics Forum-  November 21, 2019

    Stifel 2019 Healthcare Conference – November 20, 2019

    Q3 2019 Financial Results Conference Call Webcast – November 7, 2019

    Q2 2019 Financial Results Recording – August 14, 2019

    Canaccord Genuity 39th Annual Growth Conference – August 7,2019

    Q1 2019 Financial Results Recording – May 6, 2019

    Bloom Burton & Co. Healthcare Conference – April 30,2019

    Profound Medical Analyst Day – April 11,2019

    Cowen and Company 39th Annual Health Care Conference – March 13,2019

    Q4 and Full Year 2018 Financial Results Recording – March 7, 2019

    Canaccord Genuity Medical Technologies & Diagnostics Forum – November 15, 2018

    Stifel 2018 Healthcare Conference – November 14, 2018

    Q3 2018 Financial Results Recording – November 09, 2018

    Canaccord Genuity 38th Annual Growth Conference – August 8, 2018

    Q2 2018 Financial Results Recording – August 14, 2018

    Q1 2018 Financial Results Recording – May 10, 2018

    Q4 & Full Year 2017 Financial Results Recording – March 26, 2018

    Financial Reports, SEDAR+ and SEC Filings

    YearQuarterly Filings 10-Q10-K / ANNUAL INFORMATION FORMManagement Information Circular
    2025Q1| Q2 | Q310-KPDF
    Year Financial Statements MD&A 10-K / ANNUAL INFORMATION FORM Management Information Circular
    2024 Q1|Q2|Q3 Q1|Q2|Q3 10-K PDF
    2023 Q1|Q2|Q3|FY Q1|Q2|Q3|FY PDF PDF
    2022 Q1|Q2|Q3|FY Q1|Q2|Q3|FY PDF PDF
    2021 Q1|Q2|Q3|FY Q1|Q2|Q3|FY PDF PDF
    2020 Q1|Q2|Q3|FY Q1|Q2|Q3|FY PDF PDF
    Access SEDAR+ Filing
    Access SEC Filing

    Press Releases

    Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

    June 4, 2025, Press Release

    Profound Medical Annual General and Special Meeting of Shareholders Voting Results

    May 14, 2025, Press Release

    Profound Medical Announces First Quarter 2025 Financial Results

    May 8, 2025, Press Release

    Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

    April 30, 2025, Press Release

    Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

    April 29, 2025, Press Release

    Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

    April 17, 2025, Press Release

    Profound Medical AUA 2025 Investor Event Agenda

    April 15, 2025, Press Release

    Save the Date: Profound Medical to Host Investor Event at AUA 2025

    March 25, 2025, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

    March 06, 2025, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

    February 13, 2025, Press Release

    Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

    January 13, 2025, Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

    January 08, 2025, Press Release

    Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

    January 06, 2025, Press Release

    Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

    December 10, 2024, Press Release

    Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

    December 06, 2024, Press Release

    Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

    December 2nd, 2024, Press Release

    Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’

    Profound Medical to Participate in the Stifel 2024 Healthcare Conference

    November 12, 2024, Press Release

    Profound Medical Announces Third Quarter 2024 Financial Results

    November 07, 2024, Press Release

    Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

    November 04, 2024, Press Release

    Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow

    October 17, 2024, Press Release

    Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer

    October 16, 2024, Press Release

    Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA

    September 16, 2024, Press Release

    Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference

    September 04, 2024, Press Release

    Profound Medical Announces Second Quarter 2024 Financial Results

    Aug 8, 2024, Press Release

    Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

    July 18, 2024, Press Release

    Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases

    July 11, 2024, Press Release

    Profound Medical Annual General Meeting of Shareholders Voting Results

    May 15, 2024, Press Release

    Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan

    May 14, 2024, Press Release

    Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
    May 09, 2024, Press Release

    Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum

    May 06, 2024, Press Release

    Profound Medical to Release First Quarter 2024 Financial Results on

    May 9 – Conference Call to Follow

    Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference

    April 09, 2024, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results 

    March 07, 2024, Press Release

    Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

    March 04, 2024, Press Release

    Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure

    February 27, 2024, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow

    February 15, 2024, Press Release

    Profound Medical Announces Non-Brokered Private Placement

    January 16, 2024, Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

    January 03 2024, Press Release

    Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

    December 28, 2023, Press Release

    Profound Medical Announces Proposed Public Offering of Common Shares

    December 27, 2023, Press Release

    Profound Medical to Participate in the Stifel 2023 Healthcare Conference

    November 8, 2023, Press Release

    Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting

    November 3, 2023, Press Release

    Profound Medical Announces Third Quarter 2023 Financial Results

    November 2, 2023, Press Release

    Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow

    October 19, 2023, Press Release

    Profound Medical 2023 Virtual Analyst & Investor Day Agenda

    October 10, 2023, Press Release

    Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

    September 25, 2023, Press Release

    Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13

    September 21, 2023, Press Release

    Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference

    September 19, 2023 Press Release

    Profound Medical Announces At-the-Market Offering of up to US$30,000,000

    September 06, 2023 Press Release

    Profound Medical Announces Second Quarter 2023 Financial Results

    August 09, 2023, Press Release

    Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow

    August 02, 2023, Press Release

    Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases

    June 02, 2023, Press Release

    Profound Medical Announces Upcoming Investor Events

    May 30, 2023, Press Release

    Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference

    May 18, 2023, Press Release

    Profound Medical Annual and Special Meeting of Shareholders Voting Results

    May 17, 2023, Press Release

    Profound Medical Announces First Quarter 2023 Financial Results

    May 10, 2023, Press Release

    TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting

    May 1, 2023, Press Release

    Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow

    April 19, 2023, Press Release

    Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

    April 19, 2023, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results

    March 07, 2023, Press Release

    Profound Medical to Present at the 43rd Annual Cowen Health Care Conference

    Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow

    February 14, 2023, Press Release

    Profound Medical to Present at the 2022 Jefferies London Healthcare Conference

    November 08, 2022, Press Release

    Profound Medical Announces Third Quarter 2022 Financial Results

    November 03, 2022, Press Release

    Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow

    Four Year Follow-Up Data from Profound Medical’s TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer

    September 26, 2022, Press Release

    Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth

    September 15, 2022, Press Release

    Profound Medical to Participate in September Investor Conferences

    Profound Medical Provides TULSA-PRO® Reimbursement Update

    September 2, 2022, Press Release

    Profound Medical Announces Second Quarter 2022 Financial Results 
    August 4, 2022, Press Release

    Profound Medical to Release Second Quarter 2022 Financial Results on August 4 – Conference Call to Follow 
    July 14, 2022, Press Release

    Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
    June 16, 2022, Press Release

    Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference 
    June 02, 2022, Press Release

    Profound Medical Annual and Special Meeting of Shareholders Voting Results
    May 18, 2022, Press Release

    Profound Medical Clarifies Recent Insider Buying
    May 18, 2022, Press Release

    TULSA-PRO® Was Front and Center at AUA 2022
    May 17, 2022, Press Release

    Profound Medical Announces First Quarter 2022 Financial Results 
    May 9, 2022, Press Release

    Profound Medical to Participate in the 2022 Bloom Burton & Co, Healthcare Investor Conference 
    April 25, 2022, Press Release

    Profound Medical to Release First Quarter 2022 Financial Results on May 9 – Conference Call to Follow 
    April 18, 2022, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2021 Financial Results 
    March 3, 2022, Press Release

    Profound Medical to Participate in March Investor Conferences 
    March 2, 2022, Press Release

    Profound Medical’s TULSA-PRO® Now Compatible with GE Healthcare’s 3T MRI Scanners
    March 1, 2022, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2021 Financial Results on March 3- Conference Call to Follow 
    February 10, 2022, Press Release

    Profound Medical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference 
    February 8, 2022, Press Release

    Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy 
    January 18, 2022, Press Release

    Kenneth Knudson Joins Profound Medical as Chief Commercial Officer 
    January 5, 2022, Press Release

    Profound Medical Announces Third Quarter 2021 Financial Results
    November 4, 2021, Press Release

    Profound Medical to Participate in November Virtual Investor Conferences
    November 01, 2021 Press Release

    Profound Medical to Release Third Quarter 2021 Financial Results on November 4 – Conference Call to Follow
    October 18, 2021, Press Release

    Profound Medical to Participate in September Virtual Investor Conferences
    September 08, 2021 Press Release

    Profound Medical Announces Second Quarter 2021 Financial Results
    August 4, 2021, Press Release

    Profound Medical to Participate in A,G,P.’s Virtual MedTech Summer Conference
    July 22, 2021, Press Release

    Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow
    July 15, 2021, Press Release

    Profound Medical to Participate in June Investor Conferences
    May 25, 2021, Press Release

    Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes
    May 19, 2021, Press Release

    Profound Medical Announces First Quarter 2021 Financial Results
    May 12, 2021, Press Release

    Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO®
    May 06, 2021, Press Release

    Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow
    April 21, 2021, Press Release

    Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference 
    April 14, 2021, Press Release

    Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors 
    March 3, 2021, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results 
    March 2, 2021, Press Release

    Profound Medical to Participate in March Virtual Investor Conferences
    February 25, 2021, Press Release

    Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
    February 11, 2021, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
    February 9, 2021, Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues
    January 5, 2021, Press Release

    Profound Medical Signs Agreement with GE Healthcare to Expand to Provide Access to TULSA-PRO®
    December 21, 2020 Press Release

    Profound Medical Receives FDA HDE Approval for Sonalleve®
    November 30, 2020 Press Release

    Profound Medical Announces Changes to its Board of Directors
    November 30, 2020 Press Release

    Profound Medical to Participate in November Virtual Investor Healthcare Conferences
    November 10, 2020 Press Release

    Profound Medical Announces Third Quarter 2020 Financial Results
    November 05, 2020 Press Release

    Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow
    October 15, 2020 Press Release

    Profound Medical to Present at the Cantor Virtual Global Healthcare Conference
    September 9, 2020 Press Release

    Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference
    August 10, 2020 Press Release

    Profound Medical Announces Second Quarter 2020 Financial Results
    August 06, 2020 Press Release

    Profound Medical to Release Second Quarter 2020 Financial Results on August 6 – Conference Call to Follow
    July 22, 2020 Press Release

    Profound Medical Announces Closing of Offering
    July 21, 2020 Press Release

    Profound Medical Announces Pricing of Offering of Common Shares
    July 15, 2020 Press Release

    Profound Medical Announces Proposed Offering of Common Shares
    July 15, 2020 Press Release

    Profound Medical Annual and Special Meeting of Shareholders Voting Results
    May 20, 2020 Press Release

    Profound Medical Announces First Quarter 2020 Financial Results
    May 07, 2020 Press Release

    Profound Medical to Release First Quarter 2020 Financial Results on May 7 – Conference Call to Follow
    April 16, 2020 Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2019 Financial Results
    March 03, 2020 Press Release

    Profound Medical Participate in March Investor Healthcare Conferences
    February 26, 2020 Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2019 Financial Results on March 3 – Conference Call to Follow
    February 12, 2020 Press Release

    Profound Medical Retires Bank Debt Ahead of Schedule
    February 4, 2020 Press Release

    Profound Medical Announces Closing of Offering
    January 27, 2020 Press Release

    Profound Medical Announces Pricing of Offering of Common Shares
    January 22, 2020 Press Release

    Profound Medical Announces Proposed Offering of Common Shares
    January 21, 2020 Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenues & Provides TULSA-PRO® U.S. Commercialization Update
    January 10, 2020 Press Release

    Profound Medical and RadNet Sign the First-Ever U.S. Multi-Center Commercial Agreement for TULSA-PRO®
    January 10, 2020 Press Release

    Profound Medical to Present at the First Annual Bio Tuesdays Pre-JPM Virtual Conference
    December 3, 2019, Press Release

    Profound Medical Announces Health Canada Approval of TULSA-PRO®
    November 25, 2019, Press Release

    Profound Medical Announces Third Quarter 2019 Financial Results
    November 07, 2019, Press Release

    Profound to Participate in November Investor Healthcare Conferences 
    October 31, 2019, Press Release

    Profound Medical Announces Nasdaq Listing 
    October 28, 2019, Press Release

    Profound Medical to Release Third Quarter 2019 Financial Results on November 7 – Conference Call to Follow 
    October 24, 2019, Press Release

    Profound Medical Corp. Announces Share Consolidation in Connection With Proposed Nasdaq Listing
    October 11, 2019, Press Release

    Profound Medical Proposes New MJDS Registration for its Proposed U.S. Listing
    September 23, 2019, Press Release

    Profound Medical Announces Closing of Offerings
    September 20, 2019, Press Release

    Profound Medical Announces Pricing of Offerings
    September 13, 2019, Press Release

    Profound Medical Announces Proposed Offerings of Units 
    September 12, 2019, Press Release

    Profound Medical Receives U.S FDA 510(k) Clearance for TULSA-PRO®
    August 16, 2019, Press Release

    Accomplished Financial Executive, Steve Forte, Joins Profound Medical’s Board
    August 15, 2019, Press Release

    Profound Medical Announces Second Quarter 2019 Financial Results
    August 14, 2019, Press Release

    Profound Medical to Present at the Canaccord Genuity 39th Annual Growth Conference
    July 31, 2019, Press Release

    Profound Medical to Release Second Quarter 2019 Financial Results on August 14 – Conference Call to Follow
    July 30, 2019, Press Release

    Profound Medical Sells First TULSA-PRO System in Japan
    July 09, 2019, Press Release

    Profound Medical Annual and Special Meeting of Shareholders Voting Results
    June 13, 2019, Press Release

    Profound Medical Announces First Quarter 2019 Financial Results
    May 6, 2019, Press Release

    Profound Medical to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

    April 23, 2019, Press Release

    Profound Medical to Release First Quarter 2019 Financial Results on May 6 – Conference Call to Follow

    April 17, 2019, Press Release

    Profound Medical Announces First-of-its-kind TULSA-PRO Installation

    April 16, 2019, Press Release

    Profound Medical Analyst & Investor Day Agenda

    April 8, 2019, Press Release

    Profound Medical Announces Positive Topline Results from TACT Pivotal Clinical Trial of TULSA-PRO® in Patients with Prostate Cancer

    April 4, 2019, Press Release

    Profound Medical Announces Fourth Quarter and Full Year 2018 Financial Results
    March 7, 2019, Press Release

    Profound Medical to Present at the Cowen and Company 39th Annual Health Care Conference
    March 5, 2019, Press Release

    Save the Date: Profound Medical to Host Inaugural Analyst & Investor Day on April 11
    February 28, 2019, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2018 Financial Results on March 7 – Conference Call to Follow
    February 21, 2019, Press Release

    Profound Medical to participate in the 2019 BTIG MedTech, Life Science & Diagnostic Tools  Conference
    February 20, 2019, Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues
    January 3, 2019, Press Release

    Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues
    January 3, 2019, Press Release

    Profound Medical Announces Changes to Commercial Organization
    December 14, 2018, Press Release

    Profound Medical Announces Third Quarter 2018 Financial Results
    November 8, 2018, Press Release

    Profound Medical to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostiics Forum
    November 8, 2018, Press Release

    Profound Medical to Present at the Stifel 2018 Healthcare Conference
    November 7, 2018, Press Release

    Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow
    October 30, 2018, Press Release

    3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018
    September 18, 2018, Press Release

    Profound Medical Files Preliminary Base Shelf Prospectus
    September 6, 2018, Press Release

    Profound Medical Announces Second Quarter 2018 Financial Results
    August 14, 2018, Press Release

    Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow
    August 2, 2018, Press Release

    Profound Medical Present at the Canaccord Genuity 38th Annual Growth Conference
    July 31, 2018, Press Release

    Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking
    July 31, 2018, Press Release

    Profound Medical Corp. Announces Graduation to Toronto Stock Exchange
    July 11, 2018, Press Release

    Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
    June 14, 2018, Press Release

    Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
    May 21, 2018, Press Release

    Profound Medical Corp. Announces First Quarter 2018 Financial Results
    May 10, 2018, Press Release

    Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve
    May 9, 2018, Press Release

    Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
    May 2, 2018, Press Release

    Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
    May 1, 2018, Press Release

    Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
    April 25, 2018, Press Release

    Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales & Marketing Function
    April 23, 2018, Press Release

    Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results
    March 26, 2018, Press Release

    Profound Medical Corp. Announces Closing of Bought Deal Financing
    March 21, 2018, Press Release

    Profound Medical to Release Fourth Quarter and Full Year 2017 Financial Results on March 26, 2018 – Conference Call to Follow
    March 9, 2018, Press Release

    Profound Medical Corp. Upsizes Previously Announced Bought Deal Financing
    February 28, 2018, Press Release

    Profound Medical Corp. Announces $20 Million Bought Deal Financing
    February 27, 2018, Press Release

    Profound Medical to Participate in 2018 BTIG Healthcare Conference
    February 26, 2018, Press Release

    Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial
    January 31, 2018, Press Release

    Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue & Provides Progress Update on TACT Pivotal Trial Patient Enrollment  
    January 8, 2018, Press Release

    Profound Medical Corp. to Present at he 29th Annual Piper Jaffray Healthcare Conference
    November 14, 2017, Press Release

    Profound Medical Corp. Announces Third Quarter 2017 Financial Results
    November 7, 2017, Press Release

    Profound Medical Corp. Announces Expanded Clinical Use of TULSA-PRO® in Prostate Care to Include BPH
    November 6, 2017, Press Release

    Profound Medical Corp. to present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Form
    October 26, 2017, Press Release

    Profound Medical Corp. to Release Third Quarter 2017 Financial Results on    November 7, 2017 – Conference Call to Follow
    October 25, 2017, Press Release

    Profound Medical Corp. Announces Closing of $10 Million “Bought Deal” Financing
    September 20, 2017, Press Release

    Prostate cancer cure: Pinckney man part of breakthrough study
    September 20, 2017, LivingstonDaily

    Profound Makes Leap to Platform Company from Prostate Product
    September 5, 2017, BioTuesdays

    Profound Medical Corp. Announces $10 Million “Bought Deal” Financing
    August 24, 2017, Press Release

    Profound Medical Announces Second Quarter 2017 Financial Results
    August 23, 2017, Press Release

    Profound Medical Corp. to Release Second Quarter 2017 Financial Results on August 23, 2017 – Conference Call to Follow
    August 9, 2017, Press Release

    Groundbreaking Prostate Cancer Study Enters Its Final Phase
    August 7, 2017, Beaumont Health, News Release

    Profound Medical Corp. Completes Acquisition of Royal Philips’ Sonalleve MR-HIFU Business
    July 31, 2017, Press Release

    Profound Medical Corp. Announces Definitive Agreement with Royal Philips to Expand Collaboration and Acquire Sonalleve MR-HIFU Business
    June 30, 2017, Press Release

    First Hoosier prostate cancer patients treated with MRI-guided transurethral ultrasound
    June 7, 2017, Indiana University School of Medicine – Research Updates

    Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
    May 24, 2017, Press Release

    Profound Posts First-time Revenue in Q1; TACT trial 25% enrolled
    May 9, 2017, BioTuesdays

    Profound Medical Corp. Announces First Quarter 2017 Financial Results
    May 9, 2017, Press Release

    Profound Medical to Present at the CIBC Technology & Innovation Conference 5.0
    May 3, 2017, Press Release

    Profound Medical Corp. to Release First Quarter 2017 Financial Results on May 9, 2017 – Conference Call to Follow
    April 25, 2017, Press Release

    Profound Medical Corp. Obtains DTC Eligibility for its Common Shares in the U.S.
    April 18, 2017, Press Release

    Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth
    March 28, 2017, BioTuesdays

    Profound Medical Corp. Announces First Paid Procedure Using TULSA-PRO® System
    March 27, 2017, Press Release

    Profound Medical Corp. Announces Management Change
    March 24, 2017, Press Release

    Profound Medical Corp. and Philips Announce first TULSA-PRO® Sale in Finland to Turku University Hospital
    March 20, 2017, Press Release

    OTC Market Groups Welcomes Profound Medical to OTCQX
    March 13, 2017, OTC Press Release

    Profound Medical Corp. to Begin Trading on OTCQX on March 13, 2017
    March 9, 2017, Press Release

    Profound Medical Corp. Announces Fourth Quarter and Full Year 2016 Financial Results
    March 6, 2017, Press Release

    Profound Medical Corp. to Release Fourth Quarter and Full Year 2016 Financial Results on March 6, 2017 – Conference Call to Follow
    February 21, 2017, Press Release

    Profound Medical to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
    February 14, 2017, Press Release

    Profound Medical Announces Special Meeting of Shareholders Voting Results
    January 26, 2017, Press Release

    Kenneth Galbraith joins Profound Medical Board
    January 18, 2017, BioTuesdays

    Profound Medical Announces Appointment of Kenneth Galbraith to its Board of Directors
    January 17, 2017, Press Release

    Profound Medical Corp.  Announces Third Quarter 2016 Financial Results
    November 16, 2016, Press Release

    Profound Medical Corp. Completes Previously Announced $17.4 Million Bought Deal Offering of Common Shares
    November 14, 2016, Press Release

    Profound Medical Corp. to Present at the 2016 Canaccord Genuity Medical Technologies & Diagnostics Forum
    November 3, 2016, Press Release

    Profound Medical Corp. to Present at the Stifel 2016 Healthcare Conference
    November 1, 2016, Press Release

    Profound Medical Corp. to Release Third Quarter 2016 Financial Results on November 16, 2016 – Conference Call to Follow
    October 26, 2016, Press Release

    Profound Medical Corp. Announces $17.4 Million Bought Deal Financing
    October 17, 2016, Press Release

    Profound Medical Receives Frost & Sullivan’s 2016 New Product Innovation Award
    October 5, 2016, Press Release

    Profound Medical Corp. Announces First Patient Treated in TACT Pivotal Clinical Trial at Vanderbilt University Medical Center
    September 22, 2016, Press Release

    New to the Neighbourhood: Profound Medical comes to Mississauga
    September 1, 2016, Biotechnology Focus

    Profound Medical Corp. Announces Second Quarter 2016 Financial Results
    August 18, 2016, Press Release

    Profound Medical names Arun Menawat as CEO
    August 16, 2016, BioTuesdays

    Profound Medical Corp. Announces Senior Management Changes to Support Global Growth Strategy
    August 15, 2016, Press Release

    Mackie starts Profound Medical at speculative buy
    August 10, 2016, BioTuesdays

    Profound Medical Corp., to Release Second Quarter 2016 Financial Results on August 18, 2016
    August 10, 2016, Press Release

    Profound Medical Corp., Announces Annual Meeting of Shareholders Voting Results
    June 22, 2016, Press Release

    Profound Medical Corp., and Philips sell TULSA-PROTM System to University Hospital of Cologne, Germany
    June 21, 2016, Press Release

    Profound Medical Corp., and Philips sell TULSA-PROTM System to UCL and UCLH
    June 20, 2016, Press Release

    Profound Medical Corp. to hold Annual General Meeting of the Shareholders
    June 7, 2016, Press Release

    FDA Grants Profound Medical Corp. IDE Approval for TULSA-PROTM
    May 19, 2016, Press Release

    Profound Medical Corp  and Philips Sign Sales and Marketing Agreement in MRI -guided therapy in Prostate Cancer Care
    May 11, 2016, Press Release

    Profound Medical Corp  Announces First Quarter 2016 Financial Results
    May 6, 2016, Press Release

    Profound Medical Corp. to Present at Upcoming Conference 
    April 29, 2016, Press Release

    Profound Medical  Corp. to Release First Quarter 2016 Financial Results on May 6, 2016 
    April 29, 2016, Press Release

    Profound Medical Corp. Announces World’s First Sale of TULSA-PRO for Prostate Ablation
    April 28, 2016, Press Release

    Profound Earns European Approval for Prostate Device
    April 22, 2016, Focused Ultrasound Foundation

    GMP starts Profound Medical at speculative buy
    April 13, 2016, BioTuesdays

    Profound Medical Corp.  Receives CE Mark Approval for TULSA-PRO
    April 11, 2016, , Press Release

    Profound Medical Corp.  Announces Full Year 2015 Financial Results
    March 2, 2016, Press Release

    Profound Medical Corp. and Siemens Enter into Strategic Agreement to Further the Development of Prostate Cancer Care
    February 29, 2016, Press Release

    Profound Medical Corp. to Release Full Year 2015 Financial Results on March 3, 2016
    February 25, 2016, Press Release

    Profound Medical Corp., Announces Publication in European Urology
    January 8, 2016, Press Release

    Profound Medical named 2016 Life Science Company of the Year
    November 27, 2015, Press Release

    Profound Medical Corp. Announces Departure of CFO
    November17, 2015, Press Release

    Profound Medical Corp. Announces Third Quarter 2015 Financial Results
    November 5, 2015, Press Release

    Hartmut Warnken joins Profound Medical as Vice President, International Sales
    November 2, 2015, Press Release

    Profound Medical Corp. to Release Third Quarter 2015 Financial Results on November 4, 2015
    October 28, 2015, Press Release

    Profound Medical to Present at Upcoming Investor Conferences
    October 21, 2015, Press Release

    Profound Medical Presents Successful 12-Month Phase 1 Outcomes at the European Symposium on Focused Ultrasound Therapy
    October 15, 2015, Press Release

    Profound Medical to present 12-month outcomes of Phase 1 Clinical Trial at European Symposium on Focused Ultrasound Therapy
    October 13, 2015, Press Release

    Profound Medical Announces Grant of Share Options
    September 18, 2015, Press Release

    Profound Medical Corp. Announces Second Quarter 2015 Financial Results
    August 25, 2015, Press Release

    Profound Medical Corp. Announces First Quarter 2015 Financial Results of Profound Medical Inc.
    July 29, 2015, Press Release

    Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients
    July 21, 2015, Press Release

    Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
    June 23, 2015, Press Release

    Profound Medical Opens the Market
    June 15, 2015, Press Release

    Profound Medical Goes Public via Reverse Takeover
    June 1, 2015, Biotechnology Focus

    Profound Medical Corp. Announces Closing of Qualifying Transaction
    June 4, 2015, Press Release

    Profound Medical seeking CE Mark for TULSA-PRO This Year
    May 26, 2015, Bio Tuesdays

    Profound Medical and Shopify show Contrasting Ways to go Public
    May 25, 2015, Financial Post

    Mira IV Acquisition Corp. Announces Filing of Filing Statement
    May 25, 2015, News Release

    Preclinical safety and feasibility with 28-day follow-up
    May 2015, Journal of Urology, Vol. 192

    PMI Announces Going-Public Transaction and Concurrent $28 Million Financing to Fund Next Stage of Growth
    April 30, 2015, News Release

    Analyst Coverage

    FirmAnalystEmail
    Leed Jones GableDoug Loedloe@leedejonesgable.com
    Paradigm CapitalScott McAuleysmcauley@paradigmcap.com
    Raymond JamesMichael FreemanMichael.Freeman@raymondjames.ca
    StifelRick Wisewiser@stifel.com
    Lake Street Capital MarketsBen Haynor

    		ben.haynor@lakestreetcm.com

    Subscribe

    To receive a hard copy of financial information free of charge, please complete this form;

    [contact-form-7 id=”5273″ title=”Contact form Investors”]

    0 + 4 = ?

    106728B

    CAUTION: Products shown may not be approved for sale in all jurisdictions. Rx only device.
    Contact us at info@profoundmedical.com for more information regarding the regulatory status of the device.